Compile Data Set for Download or QSAR
maximum 50k data
Found 1610 Enz. Inhib. hit(s) with Target = 'Hexokinase-4'
TargetHexokinase-4(Mus musculus (Mouse))
Fujian Haixi Pharmaceuticals

US Patent
LigandPNGBDBM239068(US9409900, 65)
Affinity DataEC50:  5.00E+3nMpH: 7.1Assay Description:The final assay volume was 200 uL and the final buffer conditions used in this assay were as follows: 25 mM HEPES, 5 mM glucose, 1 mM ATP, 2 mM MgCl2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Mus musculus (Mouse))
Fujian Haixi Pharmaceuticals

US Patent
LigandPNGBDBM239066(US9409900, 13)
Affinity DataEC50:  2.00E+3nMpH: 7.1Assay Description:The final assay volume was 200 uL and the final buffer conditions used in this assay were as follows: 25 mM HEPES, 5 mM glucose, 1 mM ATP, 2 mM MgCl2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Mus musculus (Mouse))
Fujian Haixi Pharmaceuticals

US Patent
LigandPNGBDBM239065(US9409900, 6)
Affinity DataEC50:  2.00E+3nMpH: 7.1Assay Description:The final assay volume was 200 uL and the final buffer conditions used in this assay were as follows: 25 mM HEPES, 5 mM glucose, 1 mM ATP, 2 mM MgCl2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Mus musculus (Mouse))
Fujian Haixi Pharmaceuticals

US Patent
LigandPNGBDBM239067(US9409900, 78)
Affinity DataEC50:  1.50E+3nMpH: 7.1Assay Description:The final assay volume was 200 uL and the final buffer conditions used in this assay were as follows: 25 mM HEPES, 5 mM glucose, 1 mM ATP, 2 mM MgCl2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229607(US9340506, B-4)
Affinity DataEC50:  3.70E+3nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229608(US9340506, B-9)
Affinity DataEC50:  93nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM228462(BDBM229609 | US9340506, G3B)
Affinity DataEC50:  1.12E+3nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229610(US9340506, B-20)
Affinity DataEC50:  590nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229611(US9340506, B-23)
Affinity DataEC50:  480nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229612(US9340506, B-26)
Affinity DataEC50:  220nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229613(US9340506, B-49)
Affinity DataEC50:  570nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229614(US9340506, B-58)
Affinity DataEC50:  740nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229615(US9340506, C3)
Affinity DataEC50:  130nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229616(US9340506, D1)
Affinity DataEC50:  100nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM228475(BDBM229617 | US9340506, G20A)
Affinity DataEC50:  140nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229618(US9340506, E2)
Affinity DataEC50:  1.50E+3nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229619(US9340506, E3)
Affinity DataEC50:  1.20E+3nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM228461(BDBM229620 | US9340506, G1B)
Affinity DataEC50:  87nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM228461(BDBM229620 | US9340506, G1B)
Affinity DataEC50:  330nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM228462(BDBM229609 | US9340506, G3B)
Affinity DataEC50:  420nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM228464(BDBM229621 | US9340506, G4B)
Affinity DataEC50:  260nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM228464(BDBM229621 | US9340506, G4B)
Affinity DataEC50:  640nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229622(US9340506, G5A)
Affinity DataEC50:  94nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229623(US9340506, G8A)
Affinity DataEC50:  190nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229624(US9340506, G9A)
Affinity DataEC50:  270nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229625(US9340506, G10A)
Affinity DataEC50:  230nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229626(US9340506, G11A)
Affinity DataEC50:  570nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229627(US9340506, G12A)
Affinity DataEC50:  300nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229628(US9340506, G14A)
Affinity DataEC50:  380nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229629(US9340506, G15A)
Affinity DataEC50:  480nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229630(US9340506, G16A)
Affinity DataEC50:  270nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229631(US9340506, G19A)
Affinity DataEC50:  100nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM228475(BDBM229617 | US9340506, G20A)
Affinity DataEC50:  64nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229632(US9340506, G22A)
Affinity DataEC50:  290nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229633(US9340506, G25A)
Affinity DataEC50:  200nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229634(US9340506, G26A)
Affinity DataEC50:  180nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229635(US9340506, G27A)
Affinity DataEC50:  130nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229606(US9340506, A-58)
Affinity DataEC50: >1.00E+4nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229605(US9340506, A-32)
Affinity DataEC50: >1.00E+4nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229604(US9340506, A-12)
Affinity DataEC50:  660nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229602(US9340506, A-1)
Affinity DataEC50:  1.40E+3nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229603(US9340506, A-11)
Affinity DataEC50:  950nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50437899(CHEMBL2408108)
Affinity DataEC50:  2.00E+3nMAssay Description:Activation of human recombinant glucokinase by matrix assay in presence of glucoseMore data for this Ligand-Target Pair
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50437900(CHEMBL2408127)
Affinity DataEC50:  170nMAssay Description:Activation of human recombinant glucokinase by matrix assay in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50437901(CHEMBL2408129)
Affinity DataEC50:  90nMAssay Description:Activation of human recombinant glucokinase by matrix assay in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50437902(CHEMBL2408112)
Affinity DataEC50:  70nMAssay Description:Activation of human recombinant glucokinase by matrix assay in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50394684(CHEMBL2165615)
Affinity DataEC50:  190nMAssay Description:Activation of human recombinant glucokinase by matrix assay in presence of glucoseMore data for this Ligand-Target Pair
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50437903(CHEMBL2408134)
Affinity DataEC50: >1.00E+5nMAssay Description:Activation of human recombinant glucokinase by matrix assay in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50437904(CHEMBL2408111)
Affinity DataEC50:  1.03E+4nMAssay Description:Activation of human recombinant glucokinase by matrix assay in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50437905(CHEMBL2408116)
Affinity DataEC50:  9.20E+3nMAssay Description:Activation of human recombinant glucokinase by matrix assay in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 1610 total ) | Next | Last >>
Jump to: